Please use this identifier to cite or link to this item: https://repository.unej.ac.id/xmlui/handle/123456789/58725
Full metadata record
DC FieldValueLanguage
dc.contributor.authorA. Machlaurin-
dc.contributor.authorSatibi-
dc.contributor.authorN.M. Yasin-
dc.date.accessioned2014-08-07T01:00:42Z-
dc.date.available2014-08-07T01:00:42Z-
dc.date.issued2014-08-07-
dc.identifier.isbn978-979-796-291-3-
dc.identifier.urihttp://repository.unej.ac.id/handle/123456789/58725-
dc.descriptionPROCEEDING The International Conference Pharmaceutical Care "New Development of Pharmaceutical Care In a Pharmacogenetic and Pharmacogenomic Approach" University of Muhammadiyah Malang, April 19th 2014en_US
dc.description.abstractBackground : One of the most important treatment in pneumonia is antibiotic. Wide variations in antimicrobial prescribing practices exist in hospitalized pneumonia. Choice of first-line empiric treatment of pneumonia is still being debated. Objective : The objective of this study was to compare the effectiveness between ceftriaxone i.v monotherapy (CTX) vs combination therapy of ceftriaxone i.v plus ciprofloxacin i.v (CTXCP) as empiric treatment in patients with hospitalized pneumonia.en_US
dc.language.isootheren_US
dc.subjecthospitalized pneumonia, effectiveness, ceftriaxone i.v, ciprofloxacin i.ven_US
dc.titleEFFECTIVENESS COMPARATION OF INTRAVENOUS CEFTRIAXONE MONOTHERAPY VS INTRAVENOUS CEFTRIAXONE PLUS CIPROFLOXACIN COMBINATION IN HOSPITALIZED PNEUMONIAen_US
dc.typeArticleen_US
Appears in Collections:Fakultas Farmasi

Files in This Item:
File Description SizeFormat 
A. Machlaurin1_1.pdf10.59 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.